Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
Pituitary apoplexy has been reported as a rare complication of combined tests and of TRH administration in prolactinomas. A 54-year-old man with a pituitary macroadenoma had a single injection of 100 micrograms GnRH. Twenty minutes later he complained of increasing headache and vomited. These symptoms settled spontaneously and were attributed to the pharmacological effects of GnRH. Five hours later he was found to be blind and disorientated without spontaneous complaint. Emergency CT showed a large adenoma with central necrosis, consistent with pituitary apoplexy. An urgent surgical decompression was carried out and necrotic haemorrhagic debris removed. Baseline bloods revealed non-pulsatile FSH of 40 U/l with LH 0.3 U/l with no hormonal response to GnRH administration, but the sequence of events strongly suggests a causal relationship between this and pituitary apoplexy. To our knowledge this is the first time that GnRH administration has been associated with pituitary apoplexy of a glycoprotein secreting pituitary adenoma.
Masson
E A
EA
Department of Endocrinology, Royal Liverpool University Hospital, UK.
Atkin
S L
SL
Diver
M
M
White
M C
MC
D000236:Adenoma / Q000150:complications* / Q000378:metabolism; D001766:Blindness / Q000139:chemically induced*; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010899:Pituitary Apoplexy / Q000139:chemically induced*; D010911:Pituitary Neoplasms / Q000150:complications* / Q000378:metabolism
D007987:Gonadotropin-Releasing Hormone